Activation of the FPRL1 receptor results in enhanced intracellular Ca2+ levels, through which the delivery of the CB6-HA-peptide-spermidine conjugate could be demonstrated in FPRL1-expressing human breast adenocarcinoma (FPRL1/MCF-7) cells. This evidence concerns the gene FPR2 and breast adenocarcinoma.